RecruitingNCT07585097

A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Prospective Non-Interventional Study Evaluating the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS)

Sponsor

Ipsen

Enrollment

30 participants

Start Date

Jul 10, 2026

Study Type

OBSERVATIONAL

Conditions

Alagille Syndrome

Summary

This study will collect information from patients with ALGS who are using odevixibat in their daily lives. Odevixibat is a medication that helps patients with ALGS, a rare disease that affects the liver and causes itching. The main aim of this study is to observe the long-term, everyday safety of the drug odevixibat in patients with ALGS who are receiving ongoing treatment.

Eligibility

Min Age: 6 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with alagille syndrome. The study is currently recruiting participants at 14 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(14)

Hospices Civils de Lyon - Hopital Femme Mere Enfant

Bron, France

CHU Dijon Bourgogne

Dijon, France

APHP - Hopital Bicetre - Paris Sud

Le Kremlin-Bicêtre, France

APHM - CHU Timone

Marseille, France

CHU de Montpellier - Hopital Saint Eloi

Montpellier, France

APHP - Hopital Necker-Enfants Malades

Paris, France

CHU de Toulouse - Hopital Paule de Viguier

Toulouse, France

APHP - Centre Hepato-Biliaire Hospital Paul Brousse

Villejuif, France

Azienda Ospedaliero Universitaria Meyer

Florence, Italy

Azienda Ospedaliera Di Rilievo Nazionale Santobono Pausilipon

Naples, Italy

University Hospital Of Padova

Padova, Italy

IRCCS Ospedale Pediatrico Bambino Gesu

Roma, Italy

A.O.U. Citta della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita

Torino, Italy

Ospedale Universitario Di Udine

Udine, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07585097

Related Trials

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

NCT0685003810 locations

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)

NCT0729025715 locations

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

NCT0503503039 locations

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT017931682 locations

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

NCT061939288 locations